- Home
- SNCR vs BYSI Comparison
SNCR vs BYSI Comparison
Compare SNCR & BYSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNCR
- BYSI
- Stock Information
- Founded
- SNCR 2000
- BYSI 2010
- Country
- SNCR United States
- BYSI United States
- Employees
- SNCR N/A
- BYSI N/A
- Industry
- SNCR EDP Services
- BYSI Biotechnology: Pharmaceutical Preparations
- Sector
- SNCR Technology
- BYSI Health Care
- Exchange
- SNCR Nasdaq
- BYSI Nasdaq
- Market Cap
- SNCR 87.5M
- BYSI 71.0M
- IPO Year
- SNCR 2006
- BYSI 2017
- Fundamental
- Price
- SNCR $7.30
- BYSI $2.18
- Analyst Decision
- SNCR Strong Buy
- BYSI
- Analyst Count
- SNCR 1
- BYSI 0
- Target Price
- SNCR $13.00
- BYSI N/A
- AVG Volume (30 Days)
- SNCR 145.6K
- BYSI 92.5K
- Earning Date
- SNCR 08-05-2025
- BYSI 08-11-2025
- Dividend Yield
- SNCR N/A
- BYSI N/A
- EPS Growth
- SNCR N/A
- BYSI N/A
- EPS
- SNCR N/A
- BYSI N/A
- Revenue
- SNCR $172,842,000.00
- BYSI N/A
- Revenue This Year
- SNCR $2.07
- BYSI N/A
- Revenue Next Year
- SNCR $5.42
- BYSI N/A
- P/E Ratio
- SNCR N/A
- BYSI N/A
- Revenue Growth
- SNCR 4.64
- BYSI N/A
- 52 Week Low
- SNCR $6.00
- BYSI $0.98
- 52 Week High
- SNCR $15.46
- BYSI $3.44
- Technical
- Relative Strength Index (RSI)
- SNCR 54.11
- BYSI 44.93
- Support Level
- SNCR $7.03
- BYSI $2.15
- Resistance Level
- SNCR $7.67
- BYSI $2.35
- Average True Range (ATR)
- SNCR 0.44
- BYSI 0.13
- MACD
- SNCR 0.05
- BYSI -0.05
- Stochastic Oscillator
- SNCR 62.79
- BYSI 8.57
About SNCR Synchronoss Technologies Inc.
Synchronoss Technologies Inc is a provider of white-label cloud, messaging, digital and network management solutions that enable its customers to keep subscribers, systems, networks and content in sync. The Synchronoss Personal CloudTM solution is designed to create an engaging and trusted customer experience through ongoing content management and engagement. The Synchronoss Personal CloudTM platform is a secure and scalable, white-label platform that allows its customers' subscribers to backup and protect, engage with, and manage their personal content. The company derives revenue from subscriptions and transaction-based fees. A majority of the firm's revenue is generated in the United States, and the rest is from countries across the world.
About BYSI BeyondSpring Inc.
BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It operates in Plinabulin pipeline segment.